Financial Summary (All financials)
| In millions of CNY, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 173,827.4 | 141,736.2 | 154,786.1 |
| Revenue growth | 22.6% | -8.4% | |
| Cost of goods sold | 156,863.2 | 125,824.1 | 139,664.8 |
| Gross profit | 16,964.2 | 15,912.0 | 15,121.4 |
| Gross margin | 9.8% | 11.2% | 9.8% |
| Sales and marketing | 16,961.3 | 11,136.5 | 7,494.5 |
| Research and development | 9,414.6 | 6,316.8 | 5,347.4 |
| General and administrative | 28,715.2 | 7,551.0 | 6,214.9 |
| EBITA | -44,303.5 | -12,851.4 | -6,883.4 |
| EBITA margin | -25.5% | -9.1% | -4.4% |
| Amortization of intangibles | 1,824.8 | 1,993.9 | 2,109.1 |
| EBIT | -46,128.3 | -14,845.4 | -8,992.6 |
| EBIT margin | -26.5% | -10.5% | -5.8% |
| Pre-tax income | -49,168.3 | -10,910.7 | -10,081.0 |
| Income taxes | 166.3 | -303.2 | -348.0 |
| Tax rate | | 2.8% | 3.5% |
| Net income | -50,031.3 | -10,680.4 | -9,728.5 |
| Net margin | -28.8% | -7.5% | -6.3% |
| |
| Diluted EPS | ($76.04) | ($100.10) | ($96.62) |
| Shares outstanding (diluted) | 658.0 | 106.7 | 100.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|